289 related articles for article (PubMed ID: 27022275)
21. Dysregulation of microRNA expression during the progression of colorectal tumors.
Eizuka M; Osakabe M; Sato A; Fujita Y; Tanaka Y; Otsuka K; Sasaki A; Matsumoto T; Suzuki H; Sugai T
Pathol Int; 2020 Sep; 70(9):633-643. PubMed ID: 32592277
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of differentially expressed microRNA and protein expression profiles carried by exosomes in the plasma of patients with Takayasu's arteritis].
Huang BQ; Li J; Tian XP; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Jan; 62(1):61-69. PubMed ID: 36631039
[No Abstract] [Full Text] [Related]
23. MicroRNA Signatures of Colonic Polyps on Screening and Histology.
Tsikitis VL; Potter A; Mori M; Buckmeier JA; Preece CR; Harrington CA; Bartley AN; Bhattacharyya AK; Hamilton SR; Lance MP; Thompson PA
Cancer Prev Res (Phila); 2016 Dec; 9(12):942-949. PubMed ID: 27658891
[TBL] [Abstract][Full Text] [Related]
24. Unique miRomics Expression Profiles in
Aravindraja C; Jeepipalli S; Duncan W; Vekariya KM; Bahadekar S; Chan EKL; Kesavalu L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003583
[No Abstract] [Full Text] [Related]
25. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
26. Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.
Moreno EC; Pascual A; Prieto-Cuadra D; Laza VF; Molina-Cerrillo J; Ramos-Muñoz ME; Rodríguez-Serrano EM; Soto JL; Carrato A; García-Bermejo ML; Guillén-Ponce C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862091
[TBL] [Abstract][Full Text] [Related]
27. [Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].
Trukhina DA; Mamedova EO; Nikitin AG; Koshkin PA; Belaya ZE; Melnichenko GA
Probl Endokrinol (Mosk); 2024 Jan; 69(6):70-85. PubMed ID: 38311997
[TBL] [Abstract][Full Text] [Related]
28. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
Li C; Hu X; Li L; Li JH
J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
Chen Z; Liu X; Hu Z; Wang Y; Liu M; Liu X; Li H; Ji R; Guo Q; Zhou Y
Oncol Lett; 2015 Jul; 10(1):329-336. PubMed ID: 26171025
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
33. Identifying Key MicroRNAs Targeted by Narenmandula in a Rodent Nephropathy Model.
Wang X; Chang C; Jin W; Arun A; Sudunabuqi S; Aodaofu A; Liu X; Wu F; Chen H
Evid Based Complement Alternat Med; 2020; 2020():9196379. PubMed ID: 33299464
[TBL] [Abstract][Full Text] [Related]
34. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients.
Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T
Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274
[TBL] [Abstract][Full Text] [Related]
35. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma.
Zeybek A; Öz N; Kalemci S; Edgünlü T; Kızıltuğ MT; Tosun K; Tunç M; Tekin L; Erdal ME
Curr Mol Med; 2019; 19(3):216-227. PubMed ID: 30868951
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA meta-signature of oral cancer: evidence from a meta-analysis.
Zeljic K; Jovanovic I; Jovanovic J; Magic Z; Stankovic A; Supic G
Ups J Med Sci; 2018 Mar; 123(1):43-49. PubMed ID: 29482431
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.
Hamfjord J; Stangeland AM; Hughes T; Skrede ML; Tveit KM; Ikdahl T; Kure EH
PLoS One; 2012; 7(4):e34150. PubMed ID: 22529906
[TBL] [Abstract][Full Text] [Related]
39. Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China.
Cheng B; Yang R; Xu H; Wang L; Jiang N; Song T; Dong C
Biochem Genet; 2024 Jun; ():. PubMed ID: 38907084
[TBL] [Abstract][Full Text] [Related]
40. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
